414 related articles for article (PubMed ID: 20971188)
1. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex MR; Chacko AJ; Jose S; Souto EB
Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
[TBL] [Abstract][Full Text] [Related]
2. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
3. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
Müller RH; Runge SA; Ravelli V; Thünemann AF; Mehnert W; Souto EB
Eur J Pharm Biopharm; 2008 Mar; 68(3):535-44. PubMed ID: 17804210
[TBL] [Abstract][Full Text] [Related]
6. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design.
Hao J; Wang F; Wang X; Zhang D; Bi Y; Gao Y; Zhao X; Zhang Q
Eur J Pharm Sci; 2012 Sep; 47(2):497-505. PubMed ID: 22820033
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism.
Ravi PR; Aditya N; Kathuria H; Malekar S; Vats R
Eur J Pharm Biopharm; 2014 May; 87(1):114-24. PubMed ID: 24378615
[TBL] [Abstract][Full Text] [Related]
10. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV.
Ansari H; Singh P
Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641
[TBL] [Abstract][Full Text] [Related]
12. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
Negi JS; Chattopadhyay P; Sharma AK; Ram V
Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
[TBL] [Abstract][Full Text] [Related]
13. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
[TBL] [Abstract][Full Text] [Related]
14. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids.
Xie S; Zhu L; Dong Z; Wang X; Wang Y; Li X; Zhou W
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):382-7. PubMed ID: 21215599
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
Venkateswarlu V; Manjunath K
J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
[TBL] [Abstract][Full Text] [Related]
17. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
[TBL] [Abstract][Full Text] [Related]
18. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
19. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
20. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
